Shares in Advanced Oncotherapy (AVO) have been cancelled from trading on AIM as the proton beam therapy business continues to grapple with ongoing cash flow…
Shares in AVO cancelled from trading on AIM
About LaingBuisson
LaingBuisson has been serving clients for over 30 years with insights, analysis and data on market structures, policy and strategy across healthcare, social care and education.
Contact us: [email protected]
Follow LaingBuisson
©2024 All rights reserved LaingBuisson 
